ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

SYLVANT
White blood cell disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

SYLVANT Rx

Generic Name and Formulations:
Siltuximab 100mg, 400mg; lyophilized pwd for IV infusion after reconstitution; preservative-free.

Company:
Janssen Biotech, Inc.

Therapeutic Use:

Indications for SYLVANT:

Multicentric Castleman’s disease (MCD) in adults who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative. Limitation of use: not studied in patients with MCD who are HIV positive or HHV-8 positive.

Adult:

Give by IV infusion over 1 hour. 11mg/kg every 3 weeks until treatment failure.

Children:

Not established.

Warnings/Precautions:

Concurrent active severe infections: do not give siltuximab until resolved. May mask signs/symptoms of acute inflammation, fever, and acute phase reactants (eg, CRP); monitor closely. Have resuscitative equipment and personnel available. Discontinue if severe infusion-related reactions, anaphylaxis, severe allergic reactions, or cytokine release syndromes occur; do not restart. Stop infusion if mild-to-moderate infusion reactions occur; if resolves, may restart at lower infusion rate and consider using antihistamines, acetaminophen, corticosteroids. GI perforation. Perform blood tests prior to each dose for the first 12 months and every 3 dosing cycles thereafter. Consider delaying treatment if hematology criteria not met (see full labeling). Women of childbearing potential should use contraception during and for 3 months after treatment. Pregnancy (Cat.C); avoid. Nursing mothers: not recommended.

Interactions:

Concomitant live vaccines: not recommended. May antagonize CYP450 substrates; monitor drugs with narrow therapeutic index (eg, warfarin, cyclosporine, theophylline); adjust dose as needed. Decreased effectiveness with concomitant CYP3A4 substrates (eg, oral contraceptives, lovastatin, atorvastatin); caution.

Pharmacological Class:

Interleukin-6 antagonist.

Adverse Reactions:

Pruritus, increased weight, rash, hyperuricemia, upper respiratory tract infection, edema; hypersensitivity reactions.

How Supplied:

Single-use vial—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs